The results suggested that seven of the 11 selected hub genes including C3, CDK1, CCNB1, BUB1B, MAD2L1, FN1 and CDC20 may serve as potential prognostic biomarkers and therapeutic targets for GC. The gene discussed is FN1; the disease is gastric cancer.